The m7G RNA modification in gastrointestinal cancers: mechanisms and therapeutic potential

Rui Li1, Xiaoqing Lu1, Zhiyu Guan2

  • 1Guangdong Provincial Key Laboratory of Advanced Drug Delivery, Department of Biotechnology, Laboratory of Immunology and Inflammation, School of Life Sciences and Biopharmaceutics,Guangdong Pharmaceutical University, Guangzhou 510006, China.

Insights

N7-methylguanosine (m7G) modification is vital in gastrointestinal cancers. This epigenetic change impacts tumor growth, metastasis, and resistance to therapies, offering potential as a biomarker and therapeutic target.

Area of Science:

  • Epigenetics
  • Molecular Biology
  • Oncology

Background:

  • N7-methylguanosine (m7G) is an epigenetic modification regulating gene expression.
  • m7G is mediated by enzyme complexes like METTL1/WDR4 and WBSCR22/TRMT12.
  • This modification is found across various RNA types (mRNA, tRNA, rRNA, non-coding RNA).

Purpose of the Study:

  • To investigate the role of m7G modification in gastrointestinal (GI) malignant tumors.
  • To explore the association between abnormal m7G expression and GI cancer pathogenesis.
  • To evaluate the potential of m7G as a prognostic biomarker and therapeutic target in GI cancers.

Main Methods:

  • Review of literature on m7G modification in GI cancers.
  • Analysis of the mechanisms by which m7G influences oncogene translation and therapy resistance.
  • Examination of the role of m7G in regulating key signaling pathways (e.g., EGFR) and cellular processes (e.g., autophagy, DNA repair).

Main Results:

  • Abnormal m7G expression is linked to hepatocellular carcinoma, colorectal cancer, pancreatic cancer, and esophageal cancer.
  • The METTL1/WDR4 complex promotes oncogene translation via tRNA m7G modification, driving tumor proliferation, metastasis, and chemoresistance.
  • m7G modification impacts resistance to chemotherapy, targeted therapy, and radiation by modulating EGFR signaling, autophagy, and DNA repair.

Conclusions:

  • m7G modification plays a critical role in the development and progression of GI malignancies.
  • m7G modification influences tumor cell resistance to various cancer treatments.
  • m7G modification holds significant potential as a prognostic biomarker and therapeutic target for precision medicine in GI oncology.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
20.6K
RNA Editing02:23

RNA Editing

RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
8.3K
RNA Stability01:53

RNA Stability

Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
31.3K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K
Nuclear Export of mRNA02:31

Nuclear Export of mRNA

Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
7.0K